The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations | |
Shi, Puyu; Zhang, Shuo; Zhu, Lei; Qian, Guoging; Ren, Hui; Ramalingam, Suresh S.; Chen, Mingwei; Sun, Shi-Yong | |
刊名 | TRANSLATIONAL ONCOLOGY |
2019 | |
卷号 | 12页码:705-713 |
ISSN号 | 1936-5233 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2827495 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Shi, Puyu,Zhang, Shuo,Zhu, Lei,et al. The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations[J]. TRANSLATIONAL ONCOLOGY,2019,12:705-713. |
APA | Shi, Puyu.,Zhang, Shuo.,Zhu, Lei.,Qian, Guoging.,Ren, Hui.,...&Sun, Shi-Yong.(2019).The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations.TRANSLATIONAL ONCOLOGY,12,705-713. |
MLA | Shi, Puyu,et al."The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations".TRANSLATIONAL ONCOLOGY 12(2019):705-713. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论